Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-421
Closed -$28.5K 419
2025
Q3
$28.5K Buy
421
+17
+4% +$1.23K 0.01% 398
2025
Q2
$30.1K Buy
404
+1
+0.2% +$67 0.01% 345
2025
Q1
$25.3K Sell
403
-55
-12% -$3.4K 0.01% 390
2024
Q4
$26.1K Sell
458
-17
-4% -$1K 0.01% 473
2024
Q3
$27.9K Buy
475
+1
+0.2% +$55 0.01% 448
2024
Q2
$25.6K Buy
474
+2
+0.4% +$110 0.01% 464
2024
Q1
$27.2K Buy
472
+454
+2,522% +$23.5K 0.01% 433
2023
Q4
$865 Hold
18
﹤0.01% 531
2023
Q3
$921 Hold
18
﹤0.01% 547
2023
Q2
$1.03K Hold
18
﹤0.01% 572
2023
Q1
$1.08K Hold
18
﹤0.01% 647
2022
Q4
$1.05K Hold
18
﹤0.01% 644
2022
Q3
$1K Hold
18
﹤0.01% 617
2022
Q2
$1K Hold
18
﹤0.01% 622
2022
Q1
$1K Hold
18
﹤0.01% 591
2021
Q4
$836 Buy
+18
New +$820 ﹤0.01% 608

Other funds holding CTVA

Rise Advisors's CTVA Position: Q4 2025 in Review

Rise Advisors sold out of Corteva (CTVA) in Q4 2025, closing a stake of 421 shares — an estimated $28.5K sold.

Rise Advisors first reported a position in CTVA in Q4 2021 and held it in 16 quarters. The position peaked at $30.1K in Q2 2025. 1,422 funds tracked by Wall St. Rank hold CTVA as of Q4 2025.

  • Rise Advisors reported no remaining Corteva position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 421 Corteva shares in Q4 2025, an estimated $28.5K.
  • Rise Advisors first reported a position in Corteva in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Corteva position peaked at $30.1K in Q2 2025.
  • 1,422 funds tracked by Wall St. Rank held Corteva as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.